Rise in autoimmune disorders, and increase in demand for organ transplantation propels the growth of the global immunosuppressant market. North America held the highest share in 2018.
As per the report published by Allied Market Research, the global Immunosuppressants industry was estimated at $13.89 billion in 2018 and is expected to hit $42.51 billion by 2026, registering a CAGR of 14.7% from 2019 to 2026. The report offers an extensive analysis of top winning strategies, drivers & opportunities, key investment pockets, market size & share, key segments, and competitive landscape.
Rise in autoimmune disorders, and increase in demand for organ transplantation propels the growth of the global immunosuppressant market. On the other hand, lack of awareness toward organ transplantation hampers the growth to certain extent. However, various growth prospects in emerging economies are expected to provide opportunities for the key players in the industry.
Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/6288
On the basis of drug class, the calcineurin inhibitors segment accounted for nearly one-third of the global immunosuppressant market share in 2018, and is expected to dominate throughout the study period. In addition, the segment is also anticipated to grow at the fastest CAGR of 16.2% by 2026. This is attributed to increased adoption of these drugs during organ transplantation.
Based on indication, the autoimmune disorders segment contributed to nearly half of the global immunosuppressant market revenue in 2018, and is expected to rule the roost from 2019 to 2026. This is due to rise in prevalence of autoimmune disorders such as arthritis. On the other hand, the organ transplantation segment would manifest the fastest CAGR of 15.5% by 2026. Rise in use of these drugs during organ transplantation has boosted the growth of the segment.
Based on geography, North America held the highest share in 2018, generating more than two-fifths of the global immunosuppressant market. This is due to increase in incidence of auto-immune disorders in this region. However, the region across LAMEA would cite the fastest CAGR of 16.7% during the estimated period. Increase in healthcare expenditure, rise in disposable incomes, and government regulations toward making immunosuppressant drugs available for patients contribute to the market growth.
For Purchase Inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/6288
Scope of the Report:
| Report Attribute | Details |
| Market size available for years | 2019 – 2026 |
| Base year considered | 2020 |
| Forecast period | 2019 – 2026 |
| Forecast units | Value (USD) |
| Segments covered | By Drug class, By Indication, By Distribution Channel, By Region |
| Geographies covered | North America, Europe, Asia-Pacific, LAMEA |
The key market players discussed in the research include GlaxoSmithKline Plc., Pfizer, Astellas Pharma, Inc., Intas Pharmaceuticals Ltd., Johnson & Johnson, Bristol Myers Squibb, Mylan Laboratories Inc., F. Hoffmann La Roche Ltd, Sanofi S.A, Novartis AG, Inc.
Related Reports:
Infectious Immunology Market – Opportunities and Forecasts, 2020-2027
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Life Science Market: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research